Klein RL - Search Results

1

Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages.

Klein RL, Lyons TJ, Lopes-Virella MF. Klein RL, et al. Diabetologia. 1990 May;33(5):299-305. doi: 10.1007/BF00403324. Diabetologia. 1990. PMID: 2376301

2

Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages.

Klein RL, Wohltmann HJ, Lopes-Virella MF. Klein RL, et al. Diabetes. 1992 Oct;41(10):1301-7. doi: 10.2337/diab.41.10.1301. Diabetes. 1992. PMID: 1397704

3

Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages.

Klein RL, Lyons TJ, Lopes-Virella MF. Klein RL, et al. Metabolism. 1989 Nov;38(11):1108-14. doi: 10.1016/0026-0495(89)90048-6. Metabolism. 1989. PMID: 2554094

4

Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products.

Lopes-Virella MF, Klein RL, Stevenson HC. Lopes-Virella MF, et al. Among authors: klein rl. Arteriosclerosis. 1987 Mar-Apr;7(2):176-84. doi: 10.1161/01.atv.7.2.176. Arteriosclerosis. 1987. PMID: 3107536

5

Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages.

Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL. Lopes-Virella MF, et al. Among authors: klein rl. Diabetes. 1988 May;37(5):550-7. doi: 10.2337/diab.37.5.550. Diabetes. 1988. PMID: 3129328

6

Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.

Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF. Watanabe J, et al. Among authors: klein rl. Diabetes. 1988 Dec;37(12):1652-7. doi: 10.2337/diab.37.12.1652. Diabetes. 1988. PMID: 3192039

7

Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins.

Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF. Lyons TJ, et al. Among authors: klein rl. Diabetologia. 1987 Dec;30(12):916-23. doi: 10.1007/BF00295874. Diabetologia. 1987. PMID: 3436488

8

Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.

Jokl R, Klein RL, Lopes-Virella MF, Colwell JA. Jokl R, et al. Among authors: klein rl. Diabetes Care. 1995 Aug;18(8):1150-5. doi: 10.2337/diacare.18.8.1150. Diabetes Care. 1995. PMID: 7587850

9

Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.

Klein RL, Laimins M, Lopes-Virella MF. Klein RL, et al. Diabetes. 1995 Sep;44(9):1093-8. doi: 10.2337/diab.44.9.1093. Diabetes. 1995. PMID: 7657034

10

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.

Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA. Jokl R, et al. Among authors: klein rl. Diabetes Care. 1994 Aug;17(8):818-23. doi: 10.2337/diacare.17.8.818. Diabetes Care. 1994. PMID: 7956624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters